Evidence map›Paper›PMID 37047060›Full record

ArticleInternational journal of molecular sciences2023

Molecular Landscape of Pelvic Organ Prolapse Provides Insights into Disease Etiology.

Kirsten B Kluivers, Sabrina L Lince, Alejandra M Ruiz-Zapata, Wilke M Post, Rufus Cartwright, Manon H Kerkhof, Joanna Widomska, Ward De Witte, Jakub Pecanka, Lambertus A Kiemeney and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Kirsten B KluiversDepartment of Obstetrics and Gynecology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-4681-4304
Sabrina L LinceDepartment of Obstetrics and Gynecology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.ORCID 0009-0005-4862-5442
Alejandra M Ruiz-ZapataDepartment of Obstetrics and Gynecology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Wilke M PostDepartment of Obstetrics and Gynecology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-9126-0072
Rufus CartwrightDepartment of Gynaecology, Chelsea and Westminster NHS Foundation Trust, Department of Epidemiology and Biostatistics, Imperial College London, London SW7 2AZ, UK.
Manon H KerkhofDepartment of Gynaecology and Reconstructive Pelvic Surgery, Curilion Women's Health Clinic, 2015 BJ Haarlem, The Netherlands.ORCID 0000-0001-9986-763X
Joanna WidomskaDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GD Nijmegen, The Netherlands.
Ward De WitteDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
Jakub PecankaDepartment of Medical Statistics and Bioinformatics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-6857-6001
Lambertus A KiemeneyDepartment for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 EZ Nijmegen, The Netherlands.
Sita H VermeulenDepartment for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 EZ Nijmegen, The Netherlands.
Jelle J GoemanDepartment of Medical Statistics and Bioinformatics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Kristina Allen-BradyDepartment of Internal Medicine, Genetic Epidemiology, University of Utah, Salt Lake City, UT 84132, USA.
Egbert OosterwijkDepartment of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0001-5049-0018
Geert PoelmansDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
Radboud University Nijmegen · NLChelsea and Westminster Hospital NHS Foundation Trust · GBUniversity of Utah · US

Funding

IDENTIFICATION OF GENES PREDISPOSING TO PELVIC FLOOR DISORDERSR01HD061821 · NICHD · UNIVERSITY OF UTAH · PI ALBRIGHT, LISA CANNON · 2009 to 2013
$3.5M
Dutch government NWO 184.021.007Eunice Kennedy Shriver National Institute of Child Health and Human Development NIH grant RO1 HD061821European Regional Development Fund no. PROJ00787 (DIABIP)Medical Research Council G1100377NICHD NIH HHS R01 HD061821
6 · The paper itself

Abstract

Pelvic organ prolapse (POP) represents a major health care burden in women, but its underlying pathophysiological mechanisms have not been elucidated. We first used a case-control design to perform an exome chip study in 526 women with POP and 960 control women to identify single nucleotide variants (SNVs) associated with the disease. We then integrated the functional interactions between the POP candidate proteins derived from the exome chip study and other POP candidate molecules into a molecular landscape. We found significant associations between POP and SNVs in 54 genes. The proteins encoded by 26 of these genes fit into the molecular landscape, together with 43 other POP candidate molecules. The POP landscape is located in and around epithelial cells and fibroblasts of the urogenital tract and harbors four interacting biological processes-epithelial-mesenchymal transition, immune response, modulation of the extracellular matrix, and fibroblast function-that are regulated by sex hormones and TGFB1. Our findings were corroborated by enrichment analyses of differential gene expression data from an independent POP cohort. Lastly, based on the landscape and using vaginal fibroblasts from women with POP, we predicted and showed that metformin alters gene expression in these fibroblasts in a beneficial direction. In conclusion, our integrated molecular landscape of POP provides insights into the biological processes underlying the disease and clues towards novel treatments.

Indexed as

Pelvic Organ ProlapseCausalityFemaleHumansVaginaexome chip studygeneticsmetforminpelvic organ prolapsesingle nucleotide variants (SNVs)TGFB1

Identifiers

PMID37047060
PMCPMC10094264
OpenAlexW4360860549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.